These authors contributed equally to this work. Oestrogen receptor positive/ human epidermal growth factor receptor positive (ER+/HER2+) breast cancers (BCs) are less responsive to endocrine therapy ...

NanoString, which has been acquired by Bruker, has won a victory in a patent battle with 10x Genomics. Billerica, MA-based Bruker said that the German Federal Patent Court has ruled in favor of ...

A little more than two months ago, NanoString Technologies filed for bankruptcy – weary from having to pay $31 million to 10X Genomics after losing a patent infringement lawsuit. Today is a different ...

Bruker (NASDAQ:BRKR) will buy NanoString Technologies, a Seattle-based innovator in gene expression profiling and spatial transcriptomics for ~$392.6M in cash, and the assumption of certain ...

More than two months after filing for Chapter 11, NanoString Technologies has found a buyer in Bruker, which will acquire substantially all the bankrupt company’s assets for approximately $392.6 ...

Scientific instruments maker Bruker will pay about $392.6 million in cash to acquire most of the assets of Nanostring, a provider of research tools for spatial biology and gene expression, Nanostring ...

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that ...

NanoString Technologies Inc (NASDAQ:NSTG) shares are trading higher by 124.3% to $0.26 Friday afternoon after the company announced it secured a credit agreement with its existing lenders, consisting ...

NanoString Technologies (NASDAQ:NSTG) shares plunged over 46% premarket on Monday after the life science firm and certain of its subsidiaries voluntarily initiated a chapter 11 bankruptcy process to ...

After losing a patent infringement lawsuit last year that ended with an order to pay out $31 million in damages, leaving it all but hanging by a thread, NanoString Technologies is plotting a new way ...